The head of the U.S. Food and Drug Administration conceded on Tuesday that the agency could have been more aggressive in its oversight of the compounding pharmacy at the center of a deadly meningitis outbreak. Testifying at a contentious congressional …
The bankruptcy estate of the pharmacy linked to a deadly U.S. meningitis outbreak plans to battle nearly 30 states to preserve its right to redeem several million dollars worth of insurance policies for creditors. The insurance policies are key assets …
The Food and Drug Administration is warning doctors that a Georgia-based compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients. The FDA said last week that Clinical Specialties of …
A judicial panel ruled on Feb. 12 that all suits filed against a pharmacy linked to a multi-state fungal meningitis outbreak will be heard in federal court in Massachusetts. The U.S. Judicial Panel on Multidistrict Litigation has assigned Judge F. …
A bankruptcy judge on Monday froze the assets of the owners of the pharmacy linked to a deadly U.S. meningitis outbreak. Orders signed by U.S. Bankruptcy Judge Henry Boroff temporarily restrict the owners of New England Compounding Center (NECC) from …
Dennis O’Brien rubs his head as he details ailments triggered by the fungal meningitis he developed after a series of steroid shots in his neck: nausea, vomiting, dizziness, drowsiness, blurred vision, exhaustion and trouble with his speech and attention. He …
A federal judge in Boston on Wednesday allowed civil suits against the pharmacy at the heart of the deadly U.S. meningitis outbreak to proceed and noted that any criminal case would have priority in gathering evidence.U.S. District Judge Dennis Saylor …
A federal judge in Boston on Tuesday is expected to hear arguments on whether to freeze nearly $500 million in assets, including luxury homes, related to New England Compounding Center, the pharmacy linked to a deadly U.S. meningitis outbreak. U.S. …
U.S. and state health regulators called on Congress on Tuesday to strengthen federal oversight of compounding pharmacies as lawmakers prepared for two days of hearings on a deadly fungal meningitis outbreak linked to a compounded steroid. But the main federal …
The U.S. Food and Drug Administration’s power to regulate compounded drugs similar to those linked to a deadly meningitis outbreak is legally nonbinding and lacks the authority of stringent standards imposed on drug manufacturers, according to a congressional report released …
